Original article
Societal costs and survival of patients with biopsy-verified non-alcoholic steatohepatitis: Danish nationwide register-based study
Jan Håkon Rudolfsena, Lise Lotte Gluudb, Henning Grønbækc,d, Majken K. Jensene, Mogens Vybergf,g, Jens Olsena, Peter Bo Poulsenh,
, Nanna Hovelsøi, Nikolaj Ture Gregerseni, Anne Bloch Thomseni, Peter Jepsenc,d
Corresponding author
peterbo.poulsen@pfizer.com
Corresponding author. E-mail address: peterbo.poulsen@pfizer.com (P. B. Poulsen).
Corresponding author. E-mail address: peterbo.poulsen@pfizer.com (P. B. Poulsen).
a EY, DK-2000 Frederiksberg, Denmark
b Copenhagen University Hospital Hvidovre, Gastro Unit, DK-2650 Hvidovre, Denmark
c Aarhus University Hospital, Department of Hepatology & Gastroenterology, DK-8200 Aarhus, Denmark
d University of Aarhus, Department of Clinical Medicine, DK-8200 Aarhus, Denmark
e University of Copenhagen, Department of Public Health, Section of Epidemiology, Copenhagen, Denmark
f Aalborg University Campus Copenhagen, Department of Clinical Medicine, DK-2450 Copenhagen, Denmark
g Copenhagen University Hvidovre, Department of Pathology, DK-2650 Hvidovre, Denmark
h Pfizer Denmark Aps, Health & Value, DK-2750 Ballerup, Denmark
i Pfizer Denmark Aps, Medical Affairs, DK-2750 Ballerup, Denmark
Ver másRead
1528
Timeswas read the article
309
Total PDF
1219
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 28 | 6 | 34 |
| 2025 11 | 116 | 33 | 149 |
| 2025 10 | 60 | 26 | 86 |
| 2025 9 | 65 | 31 | 96 |
| 2025 8 | 60 | 11 | 71 |
| 2025 7 | 85 | 24 | 109 |
| 2025 6 | 53 | 12 | 65 |
| 2025 5 | 80 | 10 | 90 |
| 2025 4 | 66 | 10 | 76 |
| 2025 3 | 68 | 12 | 80 |
| 2025 2 | 64 | 3 | 67 |
| 2025 1 | 38 | 15 | 53 |
| 2024 12 | 36 | 5 | 41 |
| 2024 11 | 37 | 10 | 47 |
| 2024 10 | 34 | 7 | 41 |
| 2024 9 | 46 | 16 | 62 |
| 2024 8 | 46 | 9 | 55 |
| 2024 7 | 32 | 6 | 38 |
| 2024 6 | 33 | 9 | 42 |
| 2024 5 | 35 | 6 | 41 |
| 2024 4 | 40 | 8 | 48 |
| 2024 3 | 31 | 6 | 37 |
| 2024 2 | 43 | 15 | 58 |
| 2024 1 | 23 | 19 | 42 |
Show all
